These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 4844788)

  • 1. [Erythrocyte pool of the spleen in myeloproliferative and lymphoproliferative diseases].
    Friedmann B; Voslárová Z; Hermanský F; Lodrová V
    Vnitr Lek; 1974 Jul; 20(6):539-46. PubMed ID: 4844788
    [No Abstract]   [Full Text] [Related]  

  • 2. Diagnostic usefulness of acridine orange in fluorescence microscopy in certain hematological syndromes, particularly in proliferative processes.
    Topolska P; Gürtler-Krawczyńska E
    Pol Med J; 1968; 7(2):372-9. PubMed ID: 5241714
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the demonstration of fetal hemoglobins in acquired blood diseases by the elution method].
    Scholz R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1966; 86(4):419-35. PubMed ID: 4168278
    [No Abstract]   [Full Text] [Related]  

  • 4. Circulating siderocytes in human subjects.
    Kurth D; Deiss A; Cartwright GE
    Blood; 1969 Dec; 34(6):754-64. PubMed ID: 4189121
    [No Abstract]   [Full Text] [Related]  

  • 5. Serum lactic dehydrogenase activity in myeloproliferative and lymphoproliferative disorders.
    Woodliff HJ; Lynch W
    Med J Aust; 1967 Mar; 1(9):431-2. PubMed ID: 5336861
    [No Abstract]   [Full Text] [Related]  

  • 6. [Isotopie determination of serum vitamin B 12].
    Rioux E
    Union Med Can; 1969 Jan; 98(1):70-4. PubMed ID: 4883549
    [No Abstract]   [Full Text] [Related]  

  • 7. [Activity of serum alkaline deoxyribonuclease in healthy persons and in patients with lymphogranulomatosis and acute hemocytoblastosis].
    Khursin NE; Anistratenko GI
    Vrach Delo; 1968 Jan; 1():67-8. PubMed ID: 5672367
    [No Abstract]   [Full Text] [Related]  

  • 8. [The study of the survival of erythrocytes labeled with Cr51 in the diagnosis of hemolytic anemia].
    Spinelli Ressi F; Cattaneo N
    Haematol Lat; 1967; 10(2):189-99. PubMed ID: 5601215
    [No Abstract]   [Full Text] [Related]  

  • 9. The splenomegaly of myeloproliferative disorders: effects on blood volume and red blood count.
    Zhang B; Lewis SM
    Eur J Haematol; 1989 Mar; 42(3):250-3. PubMed ID: 2924887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemorrhagic infarction of the spleen in a patient with myelofibrosis, transforming to AML.
    Quinn JP; Bacon CL; O'Donnell JR; Murphy PT
    Eur J Haematol; 2004 Feb; 72(2):154. PubMed ID: 14962255
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in the inagglutinable erythrocyte count in diseases of the hematopoietic organs, collagenosis and malignant neoplasms].
    Demin AA; Kolesnik VV
    Probl Gematol Pereliv Krovi; 1968 Mar; 13(3):35-7. PubMed ID: 5246921
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow fibrosis in malignant hemopathies and cancers. Histological study of 2 786 biopsies (author's transl)].
    Duhamel G; Stachowiak J
    Sem Hop; 1981 Jan 18-25; 57(3-4):111-6. PubMed ID: 6261348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Circulating immune complexes in patients with lymphoproliferative and myeloproliferative diseases].
    Loni C; Ricci S; Azzarà A; Bertoncini G
    Quad Sclavo Diagn; 1984 Jun; 20(2):193-202. PubMed ID: 6441963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Secondary hyperuricemia in hemoblastosis].
    Richter R; Hermanny G; Hofer E; Stobbe H
    Dtsch Gesundheitsw; 1971 Nov; 26(45):2126-30. PubMed ID: 5145658
    [No Abstract]   [Full Text] [Related]  

  • 15. Idiopathic myelofibrosis with unusually high erythroblastosis in the peripheral blood.
    Osman Y; Kishi K; Narita M; Saito H; Masuko M; Koike T; Shibata A
    Am J Hematol; 1996 Jun; 52(2):122-3. PubMed ID: 8638637
    [No Abstract]   [Full Text] [Related]  

  • 16. Erythrocyte survival in leukemia, Hodgkin's disease and malignant lymphoma as determined by radiochromate.
    WAGGENER RE; PRATT PT; HUNT HB
    Am J Roentgenol Radium Ther Nucl Med; 1958 Jun; 79(6):1045-9. PubMed ID: 13533682
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of various erythrocyte enzymes of the anaerobic glycolytic pathway in systemic histocytic sarcomatoses].
    De Laurenzi A; Fontana L; Papa G
    Riv Emoter Immunoematol; 1967; 14(5):197-219. PubMed ID: 5264421
    [No Abstract]   [Full Text] [Related]  

  • 18. [Study of erythrocyte survival in relation to the predominant sites of their destruction in patients with osteomyelosclerosis and myelofibrosis].
    Sakhibov IaD; Aripov AIa
    Ter Arkh; 1968 Apr; 40(4):92-7. PubMed ID: 5740515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Unusual case of chronic myeloproliferative syndrome].
    Tosato F; Fossaluzza V
    Arch Sci Med (Torino); 1982; 139(4):531-5. PubMed ID: 6891999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The role and participation of thrombocytes in hemostasis in the myeloproliferative syndrome].
    Zaĭtseva VN
    Vrach Delo; 1971 Jan; (1):72-6. PubMed ID: 5280699
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.